1. Home
  2. NVTS vs NNNN Comparison

NVTS vs NNNN Comparison

Compare NVTS & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • NNNN
  • Stock Information
  • Founded
  • NVTS 2014
  • NNNN 2021
  • Country
  • NVTS United States
  • NNNN Germany
  • Employees
  • NVTS N/A
  • NNNN N/A
  • Industry
  • NVTS Semiconductors
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • NVTS Technology
  • NNNN Health Care
  • Exchange
  • NVTS Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • NVTS 1.9B
  • NNNN 2.2B
  • IPO Year
  • NVTS N/A
  • NNNN 2025
  • Fundamental
  • Price
  • NVTS $8.51
  • NNNN $20.91
  • Analyst Decision
  • NVTS Buy
  • NNNN
  • Analyst Count
  • NVTS 6
  • NNNN 0
  • Target Price
  • NVTS $5.92
  • NNNN N/A
  • AVG Volume (30 Days)
  • NVTS 26.6M
  • NNNN 35.0K
  • Earning Date
  • NVTS 11-03-2025
  • NNNN 04-28-2026
  • Dividend Yield
  • NVTS N/A
  • NNNN N/A
  • EPS Growth
  • NVTS N/A
  • NNNN N/A
  • EPS
  • NVTS N/A
  • NNNN 0.06
  • Revenue
  • NVTS $56,598,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • NVTS N/A
  • NNNN N/A
  • Revenue Next Year
  • NVTS $12.12
  • NNNN N/A
  • P/E Ratio
  • NVTS N/A
  • NNNN $417.85
  • Revenue Growth
  • NVTS N/A
  • NNNN 21.95
  • 52 Week Low
  • NVTS $1.52
  • NNNN $5.18
  • 52 Week High
  • NVTS $17.79
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 45.18
  • NNNN 44.83
  • Support Level
  • NVTS $6.85
  • NNNN $20.00
  • Resistance Level
  • NVTS $8.29
  • NNNN $29.38
  • Average True Range (ATR)
  • NVTS 0.83
  • NNNN 3.65
  • MACD
  • NVTS -0.08
  • NNNN 0.45
  • Stochastic Oscillator
  • NVTS 53.24
  • NNNN 41.87

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: